Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal
Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer
Tyrosine Kinase Inhibitor Encoraging For NSCLC
Novel Agents Promise Relief From Hematologic Side Effects
Interferon Alpha-2B Effective For Malignant Melanoma
International Group Plans Survey On Thrombosis Risk
NCI-Approved Clinical Trials Listed For June 2001
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









